KPC type β-lactamase, rural Pennsylvania [8]

Emerging Infectious Diseases

Volumn 12, Issue 10, 2006, Pages 1613-1614

  Pope, Jonathan ^a   Adams, Jennifer ^b   Doi, Yohei ^b   Szabo, Dora ^b,c   Paterson, David L ^b,d  

^a DuBois Regional Medical Center   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Oakland Medical Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; CEFEPIME; CEFTRIAXONE; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; KPC ENZYME; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; ENTEROBACTER INFECTION; ENZYME SYNTHESIS; FEMALE; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; LETTER; RURAL AREA; UNITED STATES;

EID: 33750029155     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1210.060297     Document Type: Letter

References (10)

1. Ricketts TC, Johnson-Webb KD, Taylor P. Definitions of rural: a handbook for healthcare policy makers and researchers. Washington: Department of Health and Human Services; 1998.
2. Stevenson KB, Searle K, Stoddard GJ, Samore M. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in rural communities, western United States. Emerg Infect Dis. 2005;11:895-903.
3. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother. 2005;49:3018-20.
4. Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother. 2004;48:4793-9.
5. Yigit H, Queenan AM, Anderson GJ, Domenench-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151-61.
6. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, et al. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents Chemother. 2003;47:3554-60.
7. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42:1089-94.
8. CTX-M genes. Clin Infect Dis. 2004;38:1736-41.
9. Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis. 2001;33:126-8.
10. Stevenson KB, Samore M, Barbera J, Moore JW, Hannah E, Houck P, et al. Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards. Diagn Microbiol Infect Dis. 2003;47:303-11.